Patient Power Founder and host, Andrew Schorr, interviews CLL expert Dr. Richard Furman to discuss the evolving CLL treatment landscape, including the introduction of venetoclax (Venclexta) to the CLL armamentarium. Venetoclax is proving to be a highly effective tool, quickly inducing deep remission particularly in patients who are genetically predisposed to developing mutations. Look for continued updates as the data on venetoclax will continue to evolve over time.
The Evolving CLL Treatment Landscape - CLL America Support
The Evolving CLL Treatment Landscape
Written by
mcints
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Shingrix efficacy for CLL
UK CLL patient and have yet to see any published results on efficacy of Shingrix for CLL patients....
obinutuzumab + venetoclax
a year long treatment.
Dr mentioned 70% of patience has 5 years remission after treatment….just...
